Search
for
Sort by
Research 31–60 of 455
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Caractérisation des Réactions Paradoxales Psoriasiformes Alopéciantes Induites par les Anti-TNFα chez des Patients Atteints de Maladies Inflammatoires Chroniques de l’Intestin
- Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease.
- S116 Treatment of Concomitant Alopecia Areata and Crohn’s Disease in a Young Child With Tofacitinib: Case Report
- Pyoderma gangrenosum presented as generalized pustules in a patient with Crohn’s disease
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Treatment modalities for lymphocytic and neutrophilic scarring alopecia
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- The skin findings of pregnant women and our treatment choices. A Turkish experience: a 5-year survey.
- PSS33 REAL-LIFE DOSING OF BIOLOGICS IN PLAQUE PSORIASIS—A GERMAN SURVEY
- Adverse Effects and Drug Interactions of Biologic Agents
- 12. Cancer
- Importance of a multi-tiered treatment approach for intellectually and developmentally disabled patients with hidradenitis suppurativa
- Importance of a multi-tiered treatment approach for intellectually and developmentally disabled patients with hidradenitis suppurativa
- A case of hidradenitis suppurativa with treatment effective by finasteride
- Trichoscan: results using a 5% minoxidil topical solution in men with androgenetic alopecia
- Trichoscopy in Unveiling the Triad of Netherton Syndrome
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- New treatments for rheumatoid arthritis
- Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment—A Single Center Case Series
- From the Cochrane Library: Interventions for Nail Psoriasis
- New developments in the treatment of systemic lupus erythematosus
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- LB1011 Cost and access changes with TNFa inhibitor biosimilars entering the market
- 0557 Possible Contributory and Protective Factors in Medication Associated Obstructive Sleep Apnea (OSA): Results from the US Food and Drug Administration (FDA) Adverse Events Reporting System (FAERS)
- 11. Psoriasis/Acne and Disorders of Keratinization
- 5. HIV, Fungal and Infectious Diseases
- 4. Bullous/Mucous Membrane
- Filaggrin mutations as an archetype for understanding the pathophysiology of atopic dermatitis
- PSS34 THE IMPACT OF POTENTIAL PILL SPLITTING ON GENERIC AND BRANDED FINASTERIDE UPTAKE